<DOC>
	<DOCNO>NCT01551797</DOCNO>
	<brief_summary>This proof principle study evaluate experimental formulation paracetamol develop eventual long lasting use . This study also use drug safety evaluation .</brief_summary>
	<brief_title>A Pharmacokinetic Study Compare Sustained Release Standard Paracetamol Formulations .</brief_title>
	<detailed_description />
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Body Mass Index ( BMI ) : Body Mass Index must range 1928 kg/m2 . Disease : Current recurrent disease could affect action , absorption , elimination disposition study medication clinical laboratory assessment ( e.g . hepatic disorder evidence abnormal liver function test , hepatitis serology test liver image study , renal insufficiency , congestive heart failure ) . Current relevant previous history serious , severe unstable physical psychiatric illness , medical disorder may require treatment make participant unlikely fully complete study , condition present undue risk study medication procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>